Literature DB >> 29032408

The natural history of depressive symptoms in patients with incident Parkinson's disease: a prospective cohort study.

Jan Petter Larsen1, Ingvild Dalen2, Kenn Freddy Pedersen3,4, Ole-Bjørn Tysnes5,6.   

Abstract

Depression is common in patients with Parkinson disease and causes suffering and increased caregiver burden. A better understanding of depressive symptoms in Parkinson disease, their progression, and risk factors may, therefore, benefit management of these patients. The present study included 187 drug-naïve patients with incident PD and 166 controls from the population-based Norwegian ParkWest project. Depressive symptoms were examined with the Montgomery and Aasberg Depression Rating Scale (MADRS) at time of diagnosis and inclusion in the study and after 1, 3, 5, and 7 years of follow-up. Associations between MADRS scores and risk factors were assessed using generalized estimating equations (GEE). The mean MADRS score from all 823 examinations during the study period was 4.2 in patients and 1.3 in 732 examinations among controls. Among controls, the occurrence of depressive symptoms was also lower and rather stable during follow-up, while in patients, we observed a decrease from time of diagnosis and until the 1-year visit, followed by a steady increase in these symptoms over time. Factors associated with higher MADRS score in the multivariable model were female sex, being dependent, higher pain score, higher Unified PD Rating Scale (UPDRS) motor score, and lower Mini-Mental State Examination (MMSE) score. The results from this study underscore the importance and frequency of depressive symptoms in patients with early PD. Furthermore, risk factors that may be considered PD-nonspecific are associated with depressive symptoms as are factors that reflect the progression of PD.

Entities:  

Keywords:  Cohort study; Depression; Epidemiology; Natural history; Non-motor symptoms; Parkinson’s disease

Mesh:

Year:  2017        PMID: 29032408     DOI: 10.1007/s00415-017-8638-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  29 in total

1.  Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

Authors:  Paolo Barone; Werner Poewe; Stefan Albrecht; Catherine Debieuvre; Dan Massey; Olivier Rascol; Eduardo Tolosa; Daniel Weintraub
Journal:  Lancet Neurol       Date:  2010-05-07       Impact factor: 44.182

Review 2.  How to measure comorbidity. a critical review of available methods.

Authors:  Vincent de Groot; Heleen Beckerman; Gustaaf J Lankhorst; Lex M Bouter
Journal:  J Clin Epidemiol       Date:  2003-03       Impact factor: 6.437

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  A three-factor model of the MADRS in major depressive disorder.

Authors:  Akihito Suzuki; Toshiaki Aoshima; Takashi Fukasawa; Keizo Yoshida; Hisashi Higuchi; Tetsuo Shimizu; Koichi Otani
Journal:  Depress Anxiety       Date:  2005       Impact factor: 6.505

Review 5.  Depression in Parkinson's disease: identification and management.

Authors:  Jack J Chen; Laura Marsh
Journal:  Pharmacotherapy       Date:  2013-06-24       Impact factor: 4.705

Review 6.  Depression in Parkinson disease--epidemiology, mechanisms and management.

Authors:  Dag Aarsland; Sven Påhlhagen; Clive G Ballard; Uwe Ehrt; Per Svenningsson
Journal:  Nat Rev Neurol       Date:  2011-12-26       Impact factor: 42.937

7.  Natural history of depression in the oldest old: population-based prospective study.

Authors:  Max L Stek; David J Vinkers; Jacobijn Gussekloo; Roos C van der Mast; Aartjan T F Beekman; Rudi G J Westendorp
Journal:  Br J Psychiatry       Date:  2006-01       Impact factor: 9.319

Review 8.  A systematic review of prevalence studies of depression in Parkinson's disease.

Authors:  Jennifer S A M Reijnders; Uwe Ehrt; Wim E J Weber; Dag Aarsland; Albert F G Leentjens
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

9.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

10.  The Natural History of Depression in Parkinson's Disease within 30-Month Follow-Up.

Authors:  Yuan-Yuan Xu; Sheng-Han Kuo; Zheng Liang; Hui Xu; Wu-Ruo Feng; Cui-Yu Yu; Wei-Guo Liu
Journal:  Parkinsons Dis       Date:  2015-02-01
View more
  2 in total

1.  Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's disease.

Authors:  Krista Specketer; Cyrus P Zabetian; Karen L Edwards; Lu Tian; Joseph F Quinn; Amie L Peterson-Hiller; Kathryn A Chung; Shu-Ching Hu; Thomas J Montine; Brenna A Cholerton
Journal:  J Clin Exp Neuropsychol       Date:  2019-06-10       Impact factor: 2.475

2.  Genome-wide Burden of Rare Short Deletions Is Enriched in Major Depressive Disorder in Four Cohorts.

Authors:  Xianglong Zhang; Abdel Abdellaoui; James Rucker; Simone de Jong; James B Potash; Myrna M Weissman; Jianxin Shi; James A Knowles; Carlos Pato; Michele Pato; Janet Sobell; Johannes H Smit; Jouke-Jan Hottenga; Eco J C de Geus; Cathryn M Lewis; Henriette N Buttenschøn; Nick Craddock; Ian Jones; Lisa Jones; Peter McGuffin; Ole Mors; Michael J Owen; Martin Preisig; Marcella Rietschel; John P Rice; Margarita Rivera; Rudolf Uher; Pablo V Gejman; Alan R Sanders; Dorret Boomsma; Brenda W J H Penninx; Gerome Breen; Douglas F Levinson
Journal:  Biol Psychiatry       Date:  2019-03-13       Impact factor: 13.382

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.